Industry payments to US neurologists related to multiple sclerosis drugs and prescribing (2015-2019): a retrospective cohort study.

ABSTRACT:

Objectives

To measure the prevalence and magnitude of industry payments to neurologists prescribing multiple sclerosis (MS) drugs and determine whether payments are associated with prescribing.

Design

Retrospective observational study.

Setting

Data on neurologists prescribing MS drugs from 2015 to 2019 in the Medicare Part D database linked to the Centers for Medicare & Medicaid Services Open Payments database.

Participants

7401 neurologists prescribing MS drugs from 2015 to 2019 to Medicare beneficiaries.

Main outcome measures

The primary outcome was the proportion of physicians' annual prescriptions manufactured by a given company. Generalised linear mixed models were used to evaluate associations between the presence and magnitude of payments and pres

SUBMITTER: Sayed A 

PROVIDER: S-EPMC12406943 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature